News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Celebrating Women Leaders: Rachna Shroff Joins Vaniam Group Event
Rachna Shroff/LinkedIn
Jun 6, 2025, 07:56

Celebrating Women Leaders: Rachna Shroff Joins Vaniam Group Event

Rachna Shroff, Associate Director Clinical Research at University of Arizona Cancer Center, posted on LinkedIn:

“What an incredible evening!
Congrats to Deanna van Gestel and Vaniam Group for creating such a beautiful community for women leaders and allies!
Thank you for letting me play a small part in it.”

Celebrating Women Leaders: Rachna Shroff Joins Vaniam Group Event

More posts featuring Rachna Shroff.

cancer Deanna van Gestel OncoDaily Oncology Rachna Shroff Vaniam Group
Special Coverage
Blog
Jul 23, 2025, 13:27
Joshua Brody: Register for the 9th Live Medical Crossfire - Hematologic Malignancies
Blog
Jul 23, 2025, 13:09
Miriam Mutebi: What Does it Really Mean to Build a Research Career in Africa?
Blog
Jul 23, 2025, 12:05
Tian Zhang: Thank You for Organizing and Inviting Us to ANZUP25
Blog
Jul 23, 2025, 11:34
Paolo Tarantino: Combining ADCs - The Future is Now
Blog
Jul 23, 2025, 11:16
Bishal Gyawali: I Enjoyed Preparing for and Giving This Talk
Blog
Jul 23, 2025, 10:45
Aren Karapetyan Thanks for the Opportunity to Moderate a Session at the ESO – OncoDaily Educational Workshop
Career
Jul 23, 2025, 10:40
Shushan Hovsepyan Is SIOP's 2025 Rising Star Award Recipient Winner
Blog
Jul 23, 2025, 10:30
Rethinking Dose Optimization: Aligning with FDA’s Project Optimus - IQVIA Research and Development Solutions
Blog
Jul 23, 2025, 10:25
Matthew Zachary: The Society for Integrative Oncology Gets It
Blog
Jul 23, 2025, 10:25
Vincent Rajkumar: Approach to Newly Diagnosed Myeloma Has Become Streamlined
Blog
Jul 23, 2025, 10:15
Advancing Osteosarcoma Research to Protect Future Generations - Children's Cancer Institute
Drugs
Jul 23, 2025, 10:05
Linvoseltamab (Lynozyfic) Approved for Myeloma: Key 2025 Updates for Patients